{"id":"W4388124188","doi":"10.1200/jco.23.00914","title":"First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":236,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Pembrolizumab; Hazard ratio; Clinical endpoint; Chemotherapy; Placebo; Internal medicine; Cervical cancer; Clinical trial; Surgery; Oncology; Confidence interval; Cancer; Immunotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004631672,0.0003242679,0.002444675,0.0002655449,0.00008758566,0.00001462914,0.0003853398,0.0004324699,0.0005656283],"category_scores_gemma":[0.002881945,0.0002234918,0.001949054,0.0004844056,0.0003646408,0.0001103201,0.00004271696,0.0007930488,0.000008389316],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003984591,"about_ca_system_score_gemma":0.002711614,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001244915,"about_ca_topic_score_gemma":0.0005075877,"domain_scores_codex":[0.9943752,0.0003603611,0.00364843,0.0004072091,0.0006833413,0.0005254742],"domain_scores_gemma":[0.9891332,0.006712109,0.002714796,0.0003597794,0.0007073451,0.0003727593],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.7909551,0.001762809,0.0008561086,0.0002709854,0.003132611,0.0001208765,0.0003215509,0.000126821,0.0002750492,0.00002294141,0.02981579,0.1723393],"study_design_scores_gemma":[0.3764836,0.08311993,0.03336552,0.0005447108,0.001279643,0.0001756486,0.0003444088,0.003079317,0.000399799,0.0001837266,0.5006567,0.000366932],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9181126,0.001599825,0.0003179958,0.07006754,0.007548921,0.001264589,0.0002400768,0.00005348909,0.0007949474],"genre_scores_gemma":[0.91641,0.05828851,0.006658674,0.005843071,0.006013761,0.0001000236,0.0001027602,0.0001818812,0.006401292],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4708409,"threshold_uncertainty_score":0.911373,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2622251498244805,"score_gpt":0.4862756760409937,"score_spread":0.2240505262165132,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}